Maimonides Medical Center   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Brooklyn NY United States (1911)

Organization Overview

First Clinical Trial
1977
NCT00000492
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Antonios Likourezos | Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY, USA | Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló | I.U. Fundación H.A. Barceló - U. Maimónides - U. Nacional Arturo Jauretche | Jocelyne Karam | Maimonides | Maimonides Biomedical Research Institute of Cordoba | Maimonides Institute for Biomedical Research in Cordoba (IMIBIC), Reina Sofia University Hospital | Maimonides Medical Center | MAIMONIDES MEDICAL CENTER, 4802, 10TH AVENUE, BROOKLYN, NY-11219 | Maimonides Medical Center Dept. of Psychiatry Chairman | Maimonides University | Minimally Invasive Surgery -Fellowship Director | Pablo Pérez Martínez | Universidad Maimónides | Universidad Maimónides - Hospital Universitario Austral

Active Ingredients

Drugs in Phase 4 Trials (27)

acetaminophen (tylenol) (3 trials)

acetylsalicylic acid (aspirin) (4 trials)

bupivacaine (Exparel) (6 trials)

dexmedetomidine (precedex) (2 trials)

diltiazem (cardizem) (1 trial)

fentanyl (Innovar) (1 trial)

guanfacine (tenex) (1 trial)

hydrocodone (hycodan) (1 trial)

ibuprofen (motrin) (2 trials)

icosapent ethyl (vascepa) (2 trials)

ketamine (ketalar) (12 trials)

ketorolac (acuvail) (3 trials)

labetalol (trandate) (1 trial)

levobupivacaine (chirocaine) (4 trials)

levothyroxine (Synthroid) (1 trial)

lidocaine (xylocaine) (2 trials)

metoprolol (lopressor) (1 trial)

misoprostol (cytotec) (1 trial)

morphine (5 trials)

nifedipine (procardia) (1 trial)

oxycodone (oxycontin) (2 trials)

oxygen (1 trial)

propofol (diprivan) (1 trial)

rimegepant (Nurtec) (1 trial)

ropivacaine (naropin) (3 trials)

sodium chloride (1 trial)

vitamin d3 (3 trials)

Drugs in Phase 3 Trials (4)

leuprolide (lupron) (1 trial)

minocycline (minocin) (1 trial)

propranolol (inderal) (1 trial)

somatropin (protropin) (1 trial)

Drugs in Phase 2 Trials (4)

colchicine (colbenemid) (1 trial)

dobutamine (dobutrex) (1 trial)

milrinone (primacor) (1 trial)

tc99m-tilmanocept (Lymphoseek) (1 trial)

Drugs in Other Trials (9)

bifidobacterium longum (1 trial)

buprenorphine (1 trial)

choline (1 trial)

cyclophosphamide (cytoxan) (1 trial)

indocyanine green (ic-green) (1 trial)

lactobacillus rhamnosus (1 trial)

naloxone (narcan) (1 trial)

naltrexone (revia) (1 trial)

prednisone (meticorten) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Pain (Phase 4)

Arthritis (Phase 4)

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 4)

Attention Deficit Disorder with Hyperactivity (Phase 4)

Cardio-Renal Syndrome (Phase 2)

Cardiovascular Diseases (Phase 3)

Coronary Disease (Phase 3)

Coronavirus Infections (Phase 2)

Death, Sudden (Phase 3)

Death, Sudden, Cardiac (Phase 3)

Dwarfism (Phase 3)

Emergencies (Phase 4)

Femoral Fractures (Phase 4)

Femoral Neck Fractures (Phase 4)

Fractures, Bone (Phase 4)

Heart Diseases (Phase 4)

Hernia (Phase 4)

Hernia, Abdominal (Phase 4)

Hip Fractures (Phase 4)

Hypertension (Phase 4)

Hypertension, Pregnancy-Induced (Phase 4)

Hypothyroidism (Phase 4)

Infertility (Phase 3)

Infertility, Female (Phase 3)

Infertility, Male (Phase 3)

Leiomyoma (Phase 4)

Musculoskeletal Pain (Phase 4)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Pain, Postoperative (Phase 4)

Polycystic Ovary Syndrome (Phase 4)

Pre-Eclampsia (Phase 4)

Rib Fractures (Phase 4)

Severe Acute Respiratory Syndrome (Phase 2)

Shoulder Pain (Phase 4)

Syndrome (Phase 4)

Ventricular Fibrillation (Phase 3)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 57
  • # of Trial APIs: 44